Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease: A Clinical Conundrum.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trial.European journal of heart failure · 2022
   Trial
2. Missed opportunities to manage complex comorbidity of heart failure, type 2 diabetes mellitus and chronic kidney disease: a retrospective cohort study.Heart (British Cardiac Society) · 2025
   Article
3. Missed opportunities to manage complex comorbidity of heart failure, type 2 diabetes mellitus and chronic kidney disease: a retrospective cohort study.Heart (British Cardiac Society) · 2025
   Article
4. A Delphi consensus project to capture experts' opinion on hyperkalaemia management across the cardiorenal spectrum.ESC heart failure · 2025
   Review
5. Epidemiological characteristics and risk factors for heart failure in Japanese patients with type 2 diabetes: A retrospective analysis of the J-DREAMS database.Journal of diabetes investigation · 2025
   Article
6. Temporal dynamics of the multi-omic response to endurance exercise training.Nature · 2024
   Article
7. Use of Diabetes Medications before and after a Heart Failure-Related Hospitalization among Nursing Home Residents.Journal of the American Medical Directors Association · 2024
   Article
8. Electrocardiogram abnormalities and renal impairment in patients with type 2 diabetes mellitus: A healthcare facilities-based cross-sectional study in Dang district of Nepal.Journal of diabetes investigation · 2023
   Article
9. Genome Editing and Diabetic Cardiomyopathy.Advances in experimental medicine and biology · 2023
   Article
10. 20 Years of Real-World Data to Estimate the Prevalence of Heart Failure and Its Subtypes in an Unselected Population of Integrated Care Units.Journal of cardiovascular development and disease · 2022
    Article
11. Premature Mortality in Type 2 Diabetes Mellitus Associated with Heart Failure and Chronic Kidney Disease: 20 Years of Real-World Data.Journal of clinical medicine · 2022
    Article
12. Diabetes Mellitus and Heart Failure.Journal of clinical medicine · 2021
    Review
13. Optimizing sodium-glucose co-transporter 2 inhibitor use in patients with heart failure with reduced ejection fraction: A collaborative clinical practice statement.American journal of preventive cardiology · 2021
    Article
14. Diabetic vasculopathy: macro and microvascular injury.Current pathobiology reports · 2020
    Article
15. Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs.Cells · 2019
    Review

Corrections and comments

• Comment on
  Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease.2016

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as